beta-lactams has been researched along with Digestive System Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lagacé-Wiens, P; Rubinstein, E | 1 |
| Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S | 1 |
| Falagas, ME; Karveli, EA; Matthaiou, DK; Peppas, G | 1 |
| Mazzei, T; Novelli, A | 1 |
3 review(s) available for beta-lactams and Digestive System Disorders
| Article | Year |
|---|---|
Adverse reactions to β-lactam antimicrobials.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Digestive System Diseases; Dose-Response Relationship, Drug; Drug Hypersensitivity; Hematologic Diseases; Humans; Kidney Diseases; Molecular Structure; Nervous System Diseases; Risk Assessment; Risk Factors; Structure-Activity Relationship | 2012 |
Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Digestive System Diseases; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
[Pharmacological rationale for choice of antibiotics for intraabdominal infections].
Topics: Abdominal Abscess; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Digestive System Diseases; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Peritonitis; Sepsis; Tigecycline; Treatment Outcome; Virginiamycin | 2008 |
1 other study(ies) available for beta-lactams and Digestive System Disorders
| Article | Year |
|---|---|
Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors | 2006 |